Skip to main content

A Phase 3, Multicenter, Open-Label, Extension Study to Evaluate the Efficacy and Safety of AK002 in Patients That Were Previously Enrolled in AK002-016 or AK002-012 Studies and have Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Allakos Inc.

Start Date

March 12, 2021

End Date

February 29, 2024
 

Administered By

Medicine, Gastroenterology

Awarded By

Allakos Inc.

Start Date

March 12, 2021

End Date

February 29, 2024